← Back to Analyst Consensus 
CLMT Hold
Calumet, Inc. /DE
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 6, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 2, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 25, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Aug 18, 2026 | Goldman Sachs | maintain | Neutral → Neutral | — | 54% |
| Aug 12, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| Jul 30, 2026 | Goldman Sachs | maintain | Neutral → Neutral | — | 54% |
| Mar 30, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 12, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Jan 30, 2026 | Goldman Sachs | maintain | Buy → Buy | $24 | 54% |
| Nov 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $33 | 44% |
| Oct 22, 2025 | Goldman Sachs | maintain | Buy → Buy | $20 | 54% |
| Aug 12, 2025 | UBS | maintain | Neutral → Neutral | $13.25 | 54% |
| May 14, 2025 | Wells Fargo | maintain | Overweight → Overweight | $21 | 54% |
| May 13, 2025 | B of A Securities | initiate | — → Buy | $15 | 53% |
| Apr 30, 2025 | Goldman Sachs | maintain | Buy → Buy | $14 | 54% |
| Apr 9, 2025 | Wells Fargo | maintain | Overweight → Overweight | $23 | 54% |
| Mar 17, 2025 | UBS | upgrade | Sell → Neutral | $12 | 54% |
| Mar 5, 2025 | Wells Fargo | maintain | Overweight → Overweight | $28 | 54% |
| Mar 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $33 | 44% |
| Feb 12, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $33 | 44% |
| Feb 4, 2025 | UBS | downgrade | Neutral → Sell | $15 | 54% |
| Jan 13, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $33 | 44% |
| Nov 11, 2024 | TD Cowen | maintain | Buy → Buy | $26 | 54% |
| Nov 11, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Aug 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Aug 12, 2024 | TD Cowen | maintain | Buy → Buy | $18 | 54% |
| Aug 5, 2024 | Goldman Sachs | maintain | Buy → Buy | $15 | 54% |
| May 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Apr 22, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Mar 21, 2024 | Goldman Sachs | maintain | Buy → Buy | $17 | 54% |
| Dec 14, 2023 | Goldman Sachs | maintain | Buy → Buy | $19 | 54% |
| Oct 31, 2023 | Goldman Sachs | maintain | Buy → Buy | $17 | 54% |
| Aug 7, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $25 | 44% |
| Jun 13, 2023 | Goldman Sachs | maintain | — → Buy | $19 | 54% |
| May 15, 2023 | UBS | maintain | Neutral → Neutral | $19.5 | 54% |
| May 8, 2023 | Wells Fargo | maintain | — → Overweight | $27 | 54% |
| May 8, 2023 | TD Cowen | maintain | — → Outperform | $23 | 54% |
| Jan 25, 2023 | HC Wainwright & Co. | maintain | — → Buy | $25 | 44% |
| Dec 14, 2022 | UBS | initiate | — → Neutral | $15.7 | 54% |
| Aug 18, 2022 | Goldman Sachs | upgrade | Neutral → Buy | $23 | 54% |
| Jun 28, 2022 | Cowen & Co. | maintain | — → Outperform | $20 | — |
| May 9, 2022 | Cowen & Co. | maintain | — → Outperform | $20 | — |
| Apr 21, 2022 | Wells Fargo | maintain | — → Overweight | $29 | 54% |
| Feb 28, 2022 | HC Wainwright & Co. | maintain | — → Buy | $28 | 44% |
| Nov 23, 2021 | Wolfe Research | upgrade | Peer Perform → Outperform | $30 | 54% |
| Nov 23, 2021 | Cowen & Co. | upgrade | Market Perform → Outperform | $23 | — |
| Oct 15, 2021 | Goldman Sachs | maintain | — → Neutral | $11 | 54% |
| Oct 8, 2021 | Wells Fargo | maintain | — → Overweight | $11 | 54% |
| Oct 4, 2021 | HC Wainwright & Co. | initiate | — → Buy | $19 | 44% |
| Mar 24, 2021 | Wells Fargo | upgrade | Equal-Weight → Overweight | $8 | 54% |
| Dec 15, 2020 | Wells Fargo | downgrade | Overweight → Equal-Weight | $4 | 54% |
Price Target Trend
Apr 1, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days